Percutaneous aortic valve therapy: Clinical experience and the role of multi-modality imaging

Heart

Volumn 95, Issue 18, 2009, Pages 1538-1546

  Tops, Laurens F ^a   Delgado, Victoria ^a   Van Der Kley, Frank ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; BLEEDING; CARDIOPULMONARY BYPASS; CARDIOVASCULAR DISEASE; CLINICAL PRACTICE; FOLLOW UP; HUMAN; IMAGING; MORTALITY; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PERICARDIAL EFFUSION; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

AORTIC VALVE; DIAGNOSTIC IMAGING; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PATIENT SELECTION;

EID: 69549115185     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.151498     Document Type: Review

References (22)

1. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268 ▶ Current ESC guidelines on the management of patients with valvular heart disease, including aortic stenosis.
2. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243 ▶ This survey provides important information on the characteristics and management of patients with valvular heart disease in Europe. The survey included data of 5001 patients from 92 centres in 25 countries.
3. Vahanian A, Alfieri O, Al Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2008;29:1463-1470 ▶ This is the first official statement that provides important recommendations on the patient selection, implantation procedures, and follow-up for percutaneous aortic valve implantation.
4. Vassiliades TA Jr, Block PC, Cohn LH, et al. The clinical development of percutaneous heart valve technology: a position statement of the Society of Thoracic Surgeons (STS), the American Association for Thoracic Surgery (AATS), and the Society for Cardiovascular Angiography and Interventions (SCAI) endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA). J Am Coll Cardiol 2005;45:1554-1560
5. Rosengart TK, Feldman T, Borger MA, et al. Percutaneous and minimally invasive valve procedures: a scientific statement from the American Heart Association Council on Cardiovascular Surgery and Anesthesia, Council on Clinical Cardiology, Functional Genomics and Translational Biology Interdisciplinary Working Group, and Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2008;117:1750-1767 ▶ This is a more general statement on the development of percutaneous valve procedures, including aortic and mitral valve procedures.
6. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-708
7. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-3008 ▶ This is the first report of the percutaneous implantation of a balloon expandable aortic valve in a patient with severe aortic stenosis. (Pubitemid 35440280)
8. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850 (Pubitemid 43754305)
9. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-596 (Pubitemid 44202060)
10. Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol 2004;43:698-703. (Pubitemid 38229547)
11. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-1223
12. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-763 (Pubitemid 47255993)
13. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
14. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Intervent 2008;1:167-175
15. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465-469 ▶ This is the first report of the implantation of the selfexpanding CoreValve prosthesis.
16. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-inman study. Circulation 2006;114:1616-1624 (Pubitemid 44547432)
17. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 2008;4:242-249 ▶ This is the largest published study to date using the self expanding CoreValve Revalving system. It involves a multicentre registry following CE mark approval of the device, and demonstrates a high procedural success rate and a low 30 day mortality.
18. Walther T, Falk V, Dewey T, et al. Valve-in-a-valve concept for transcatheter minimally invasive repeat xenograft implantation. J Am Coll Cardiol 2007;50:56-60. ▶ This is the first report of the valve-in-valve concept in an animal model. (Pubitemid 46970876)
19. Zegdi R, Ciobotaru V, Noghin M, et al. Is it reasonable to treat all calcified stenotic aortic valves with a valved stent? Results from a human anatomic study in adults. J Am Coll Cardiol 2008;51:579-584
20. Tops LF, Wood DA, Delgado V, et al. Noninvasive evaluation of the aortic root with multislice computed tomography: implications for transcatheter aortic valve replacement. J Am Coll Cardiol Img 2008;1:321-330 ▶ This study demonstrates the value of MSCT in planning percutaneous aortic valve implantation procedures. MSCT can provide detailed information on the aortic annulus, and the relation with the coronary ostia, based on a three dimensional reconstructed image.
21. Moss R, Ivens E, Pasupati S, et al. Role of echocardiography in percutaneous aortic valve implantation. J Am Coll Cardiol Img 2008;1:15-24.
22. Chiam PTL, Ruiz CE. Percutaneous transcatheter aortic valve implantation: assessing results, judging outcomes, and planning trials: the interventionalist perspective. J Am Coll Cardiol Intv 2008;1:341-350